Discover how cannabinoid research is revolutionizing periodontal disease treatment through the body's natural endocannabinoid system and CB2 receptors.
Explore the therapeutic potential of JWH133, a CB2 receptor-selective agonist offering anti-inflammatory benefits without psychoactive effects.